Article: Sentinel lymph node biopsy in patients with multicentric/multifocal breast cancer: low false-negative rate and lack of axillary recurrence

Background: Accuracy of sentinel lymph node biopsy (SLNB) and rate of axillary recurrence in multicentric/multifocal (MC/MF) breast cancer are reported.

Methods: From 1999 to 2006, 93 patients with MC/MF breast cancer underwent SLNB; 41 underwent axillary lymph node dissection regardless of SLN pathology (group 1), and 52 underwent axillary lymph node dissection only if an SLN was positive (group 2). Patient demographics, SLN techniques, and pathology were recorded.

Results: There were no differences between the 2 groups with respect to patient age; tumor size, grade, stage, and histology; or method of SLN detection. The incidence of axillary metastasis was greater in group 1 patients (68%) compared with group 2 patients (12%) (P < .01). In group 1, the sensitivity and specificity of SLNB were 93% and 100%, respectively, with a false-negative rate of 7%. None of the 52 patients in group 2 experienced axillary recurrence (median follow-up 4.8 years).

Conclusions: The accuracy of SLNB in MC/MF breast cancer is comparable with that observed in unifocal breast cancer. Despite a lower rate of SLN positivity in patients undergoing SLNB only, axillary recurrence was not observed.

Citing Articles

Is Routine Axillary Imaging Necessary in Clinically Node-Negative Patients Undergoing Neoadjuvant Chemotherapy?.

Barrio A, Mamtani A, Eaton A, Brennan S, Stempel M, Morrow M Ann Surg Oncol. 2017; 24(3):645-651.

PMID: 28130619 PMC: 5388138. DOI: 10.1245/s10434-017-5765-y.

Sentinel node biopsy for breast cancer patients: issues for discussion and our practice.

Pechlivanides G, Vassilaros D, Tsimpanis A, Apostolopoulou A, Vasilaros S Patholog Res Int. 2011; 2011:109712.

PMID: 21234361 PMC: 3018621. DOI: 10.4061/2011/109712.

References

1.

Knauer M, Konstantiniuk P, Haid A, Wenzl E, Riegler-Keil M, Postlberger S . Multicentric breast cancer: a new indication for sentinel node biopsy--a multi-institutional validation study. J Clin Oncol. 2006; 24(21):3374-80. DOI: 10.1200/JCO.2006.05.7372. View

2.

Coombs N, Boyages J . Multifocal and multicentric breast cancer: does each focus matter?. J Clin Oncol. 2005; 23(30):7497-502. DOI: 10.1200/JCO.2005.02.1147. View

3.

Krag D, Anderson S, Julian T, Brown A, Harlow S, Ashikaga T . Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007; 8(10):881-8. DOI: 10.1016/S1470-2045(07)70278-4. View

4.

Gentilini O, Trifiro G, Soteldo J, Luini A, Intra M, Galimberti V . Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of Oncology. Eur J Surg Oncol. 2006; 32(5):507-10. DOI: 10.1016/j.ejso.2006.02.018. View

5.

Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S . Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999; 91(4):368-73. DOI: 10.1093/jnci/91.4.368. View

6.

McMasters K, Tuttle T, Carlson D, Brown C, Noyes R, Glaser R . Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000; 18(13):2560-6. DOI: 10.1200/JCO.2000.18.13.2560. View

7.

Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg V, Shriver C . The sentinel node in breast cancer--a multicenter validation study. N Engl J Med. 1998; 339(14):941-6. DOI: 10.1056/NEJM199810013391401. View

8.

Vlastos G, Rubio I, Mirza N, Newman L, Aurora R, Alderfer J . Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer. Ann Surg Oncol. 2000; 7(8):581-7. DOI: 10.1007/BF02725337. View

9.

Tousimis E, Van Zee K, Fey J, Hoque L, Tan L, Cody 3rd H . The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J Am Coll Surg. 2003; 197(4):529-35. DOI: 10.1016/S1072-7515(03)00677-X. View

10.

Kumar R, Jana S, Heiba S, Dakhel M, Axelrod D, Siegel B . Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. J Nucl Med. 2003; 44(1):7-10. View

11.

Tuttle T, Colbert M, Christensen R, Ose K, Jones T, Wetherille R . Subareolar injection of 99mTc facilitates sentinel lymph node identification. Ann Surg Oncol. 2002; 9(1):77-81. DOI: 10.1245/aso.2002.9.1.77. View

Sentinel Lymph Node Biopsy in Patients with Multicentric/multifocal Breast Cancer: Low False-negative Rate and Lack of Axillary Recurrence